Asia-Pacific Mobile Health Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 20.93 Billion |
| Market Size (2029) | USD 61.91 Billion |
| CAGR (2024 - 2029) | 24.22 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Asia-Pacific Mobile Health Market Analysis
The Asia-Pacific Mobile Health Market size is estimated at USD 20.93 billion in 2024, and is expected to reach USD 61.91 billion by 2029, growing at a CAGR of 24.22% during the forecast period (2024-2029).
The use of mobile devices by healthcare professionals has transformed many aspects of clinical practice in the Asia-Pacific region. It has led to the rapid growth in the development of medical software applications (apps) for these platforms.
Mobile devices and apps provide many benefits for healthcare professionals, most significantly the increased access to point-of-care tools, to support better clinical decision making and improved patient outcomes.
Moreover, factors such as increased awareness levels among the people, about the potential benefits of healthcare management, increased need of point-of-care diagnosis and treatment, and increasing focus on personalized medicine and patient-centered approach, are driving the growth of the mobile health market.
In addition, the rapid technological advancements in mHealth research generate both opportunities and challenges, including creating scalable systems that are capable of collecting unprecedented amounts of data and conducting interventions, while protecting the privacy and safety of the research participants. Additionally, the stringent regulatory policies for mHealth applications are expected to restrain the market's growth.
Asia-Pacific Mobile Health Market Trends
This section covers the major market trends shaping the APAC Mobile Health Market according to our research experts:
Neurological Monitors are Expected to Register a High Growth Rate Over the Forecast Period
Neurological monitors mainly utilize brain wave activity, namely, the electroencephalogram (EEG). The constituent components of the neurological monitor are the electrodes, amplifiers, analog‐to‐digital converter (ADC), and the monitoring display. Neurological diagnostic monitoring is accomplished using quantitative EEG analysis for assessment of the ongoing brain activity.
Neurological monitoring is very important, especially in case of pateints with neurological diseases like dementia. Dementia is highly prevalent in the elderly population. As per reports by the United Nations, Asia-Pacific counties like Japan, China and Australia have very high percentage of population aged 60 years or above and is further expected to increase in future as well. This is expected to increase the incidence of neurological illnesses in the region, which will increase the demand for neurological monitoring devices. This will help the market growth in the region.
Asia-Pacific Mobile Health Industry Overview
Most of the countries in the Asia-Pacific region are developing economies. These developing economies have high numbers of people with unattended neurological conditions and diseases. As a result, these countries have high potential for mobile and remote care, and hence, are highly lucrative for the global players to enter. Moreover, some regional players have established their presence in the region.
Asia-Pacific Mobile Health Market Leaders
-
Philips Healthcare
-
Medtronic PLC
-
Johnson & Johnson
-
Cisco Systems Inc
-
Samsung Healthcare Solutions
*Disclaimer: Major Players sorted in no particular order
Asia-Pacific Mobile Health Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Deliverables
- 1.2 Study Assumptions
- 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Usage of Smartphones, Tablets, and Mobile Technology in Healthcare
- 4.2.2 Increased Need for Point-of-care Diagnosis and Treatment
-
4.3 Market Restraints
- 4.3.1 Data Security Issues
- 4.3.2 Stringent Regulatory Policies for mHealth Applications
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Service Type
- 5.1.1 Monitoring Services
- 5.1.2 Diagnostic Services
- 5.1.3 Treatment Services
- 5.1.4 Wellness and Fitness Solutions
- 5.1.5 Other Service Types
-
5.2 By Device Type
- 5.2.1 Blood Glucose Monitors
- 5.2.2 Cardiac Monitors
- 5.2.3 Hemodynamic Monitors
- 5.2.4 Neurological Monitors
- 5.2.5 Respiratory Monitors
- 5.2.6 Body and Temperature Monitors
- 5.2.7 Remote Patient Monitoring Devices
- 5.2.8 Other Device Types
-
5.3 By Stakeholder
- 5.3.1 Mobile Operators
- 5.3.2 Healthcare Providers
- 5.3.3 Application/Content Players
- 5.3.4 Other Stakeholders
-
5.4 By Geography
- 5.4.1 Asia-Pacific
- 5.4.1.1 China
- 5.4.1.2 Japan
- 5.4.1.3 India
- 5.4.1.4 Australia
- 5.4.1.5 South Korea
- 5.4.1.6 Rest of Asia-Pacific
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 AT&T Inc.
- 6.1.2 Bayer Healthcare
- 6.1.3 Cerner Corporation
- 6.1.4 Cisco Systems Inc.
- 6.1.5 Johnson & Johnson
- 6.1.6 Medtronic PLC
- 6.1.7 Omron Corporation
- 6.1.8 Philips Healthcare
- 6.1.9 Qualcomm Life
- 6.1.10 Samsung Healthcare Solutions
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityAsia-Pacific Mobile Health Industry Segmentation
Mobile health or mHealth is a component of eHealth. Generally, mHealth or mobile health is defined as a medical and public health practice, supported by mobile devices, such as mobile phones, patient monitoring devices, personal digital assistants (PDAs), and other wireless devices.
| By Service Type | Monitoring Services | |
| Diagnostic Services | ||
| Treatment Services | ||
| Wellness and Fitness Solutions | ||
| Other Service Types | ||
| By Device Type | Blood Glucose Monitors | |
| Cardiac Monitors | ||
| Hemodynamic Monitors | ||
| Neurological Monitors | ||
| Respiratory Monitors | ||
| Body and Temperature Monitors | ||
| Remote Patient Monitoring Devices | ||
| Other Device Types | ||
| By Stakeholder | Mobile Operators | |
| Healthcare Providers | ||
| Application/Content Players | ||
| Other Stakeholders | ||
| By Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific |
Asia-Pacific Mobile Health Market Research FAQs
How big is the Asia-Pacific Mobile Health Market?
The Asia-Pacific Mobile Health Market size is expected to reach USD 20.93 billion in 2024 and grow at a CAGR of 24.22% to reach USD 61.91 billion by 2029.
What is the current Asia-Pacific Mobile Health Market size?
In 2024, the Asia-Pacific Mobile Health Market size is expected to reach USD 20.93 billion.
Who are the key players in Asia-Pacific Mobile Health Market?
Philips Healthcare, Medtronic PLC, Johnson & Johnson, Cisco Systems Inc and Samsung Healthcare Solutions are the major companies operating in the Asia-Pacific Mobile Health Market.
What years does this Asia-Pacific Mobile Health Market cover, and what was the market size in 2023?
In 2023, the Asia-Pacific Mobile Health Market size was estimated at USD 16.85 billion. The report covers the Asia-Pacific Mobile Health Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia-Pacific Mobile Health Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Asia Pacific mHealth Industry Report
Statistics for the 2024 Asia Pacific mHealth market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Asia Pacific mHealth analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
